Literature DB >> 16610064

Local regulator adrenomedullin contributes to the circulatory disturbance in cirrhotic rats.

Shinya Sakurai1, Hideyuki Kojima, Masahito Uemura, Hiroyasu Satoh, Hiroshi Fukui.   

Abstract

AIM: To investigate whether adrenomedullin, a potent vasodilator peptide, plays a role in the circulatory disturbance in cirrhosis.
METHODS: Cirrhosis was induced in rats by weekly gavage of carbon tetrachloride. Hemodynamic studies were performed in vivo using radioactive microspheres and in vitro using isolated aortic rings. The adrenomedullin concentrations were measured by radioimmunoassay.
RESULTS: Acute administration of adrenomedullin to the control rats reduced the systemic arterial pressure along with an increase of serum levels of the stable metabolite of nitric oxide (NOx), in a dose-dependent manner. Chronic infusion of adrenomedullin reduced the vascular resistance and increased the blood flow in the systemic and splanchnic circulation. Intravenous administration of anti-adrenomedullin antibody did not affect any hemodynamic parameters in the cirrhotic rats, whereas this antibody ameliorated the blunted contractile response to phenylephrine, alpha-adrenergic receptor agonist, in the aortic rings of the cirrhotic rats. The adrenomedullin concentrations in the aorta were higher in the cirrhotic rats than in the controls, and correlated with the mean arterial pressure in the cirrhotic rats. Moreover, adrenomedullin blunted the contractile response to phenylephrine in both of the control aorta and cirrhotic aorta, but not in the presence of NG-nitro-L-arginine methyl ester, an NO synthase inhibitor.
CONCLUSION: Adrenomedullin overproduced in the vascular wall may contribute to the circulatory disturbance in cirrhosis as a local regulator of the vascular tonus rather than a circulating hormone.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16610064      PMCID: PMC4087692          DOI: 10.3748/wjg.v12.i13.2095

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  33 in total

1.  Mixed endothelin receptor antagonist, SB209670, decreases portal pressure in biliary cirrhotic rats in vivo by reducing portal venous system resistance.

Authors:  H Kojima; J Yamao; T Tsujimoto; M Uemura; A Takaya; H Fukui
Journal:  J Hepatol       Date:  2000-01       Impact factor: 25.083

2.  Ligand: a versatile computerized approach for characterization of ligand-binding systems.

Authors:  P J Munson; D Rodbard
Journal:  Anal Biochem       Date:  1980-09-01       Impact factor: 3.365

3.  Increased circulating calcitonin gene-related peptide (CGRP) in cirrhosis.

Authors:  F Bendtsen; S Schifter; J H Henriksen
Journal:  J Hepatol       Date:  1991-01       Impact factor: 25.083

4.  Excessive in vitro bacterial lipopolysaccharide-induced production of monokines in cirrhosis.

Authors:  J Devière; J Content; C Denys; P Vandenbussche; L Schandene; J Wybran; E Dupont
Journal:  Hepatology       Date:  1990-04       Impact factor: 17.425

5.  Anesthetic influences on regional hemodynamics in normal and hemorrhaged rats.

Authors:  W C Seyde; D E Longnecker
Journal:  Anesthesiology       Date:  1984-12       Impact factor: 7.892

6.  Increased vascular heme oxygenase-1 expression contributes to arterial vasodilation in experimental cirrhosis in rats.

Authors:  Yung-Chang Chen; Pere Ginès; Jianhui Yang; Sandra N Summer; Sandor Falk; Nash S Russell; Robert W Schrier
Journal:  Hepatology       Date:  2004-04       Impact factor: 17.425

7.  Adrenomedullin contributes to vascular hyporeactivity in cirrhotic rats with ascites via a release of nitric oxide.

Authors:  H Kojima; S Sakurai; M Uemura; H Satoh; T Nakashima; N Minamino; K Kangawa; H Matsuo; H Fukui
Journal:  Scand J Gastroenterol       Date:  2004-07       Impact factor: 2.423

8.  High yield micronodular cirrhosis in the rat.

Authors:  E Proctor; K Chatamra
Journal:  Gastroenterology       Date:  1982-12       Impact factor: 22.682

Review 9.  Peripheral arterial vasodilation hypothesis: a proposal for the initiation of renal sodium and water retention in cirrhosis.

Authors:  R W Schrier; V Arroyo; M Bernardi; M Epstein; J H Henriksen; J Rodés
Journal:  Hepatology       Date:  1988 Sep-Oct       Impact factor: 17.425

10.  Simvastatin enhances hepatic nitric oxide production and decreases the hepatic vascular tone in patients with cirrhosis.

Authors:  Carmen Zafra; Juan G Abraldes; Juan Turnes; Annalisa Berzigotti; Mercedes Fernández; Juan C Garca-Pagán; Juan Rodés; Jaime Bosch
Journal:  Gastroenterology       Date:  2004-03       Impact factor: 22.682

View more
  2 in total

1.  Physiopathology of splanchnic vasodilation in portal hypertension.

Authors:  María Martell; Mar Coll; Nahia Ezkurdia; Imma Raurell; Joan Genescà
Journal:  World J Hepatol       Date:  2010-06-27

2.  Upregulated expression of hypoxia reactive genes in peripheral blood mononuclear cells from chronic liver disease patients.

Authors:  Akifumi Kuwano; Masatake Tanaka; Hideo Suzuki; Miho Kurokawa; Koji Imoto; Shigeki Tashiro; Takeshi Goya; Motoyuki Kohjima; Masaki Kato; Yoshihiro Ogawa
Journal:  Biochem Biophys Rep       Date:  2021-07-14
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.